Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-07

Clinical Trial Update: Nevirapine Plus Zidovudine to Prevent Perinatal HIV in Thailand [Phase 3]

View source ↗

Summary

A Phase 3 trial in Thailand assessing nevirapine plus zidovudine to prevent perinatal HIV transmission has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RETROVIR (Zidovudine)
  • Viramune (Nevirapine)

Snippet

Sponsor: Institut de Recherche pour le Developpement | Conditions: HIV Infections, Pregnancy | Phase 3 | Status: COMPLETED